Overview


Robert (Bob) H. Underwood, PhD, helps clients achieve business objectives by drawing on his extensive experience establishing US and international intellectual property (IP) rights and identifying and evaluating third-party IP risks. He focuses his practice on the life sciences and chemical industries, including biologic and small-molecule pharmaceuticals and diagnostics, vaccines, medical devices, food science and nutritional supplements, agricultural technology, renewable and clean chemical technology, organic chemistry, polymers and catalysts.

Show More

Results


  • Serves as IP counsel to Novartis on several transactions, including the approximately $7 billion sale of its vaccines business to GlaxoSmithKline, the sale of its influenza vaccines business to CSL and in evaluating business development opportunities
  • Serves as counsel to pharmaceutical companies for early stage evaluation of potential in-licensing and M&A opportunities
  • Served as IP transaction counsel, pro bono, to the ALS association

Show More

Recognition


  • Chambers USA 2012 to present
  • Intellectual Asset Management (IAM) Patent 1000 – The World’s Leading Patent Practitioners 2012 to present
  • The Legal 500 US 2014 to present
  • World Intellectual Property Review patent leader 2016 to present

Credentials


Education
Suffolk University Law School, JD, cum laude, 2005
Tufts University, PhD, Immunology, 1998
University of New Hampshire, BS, Biology, 1989

Admissions
Massachusetts

Courts / Agencies
US Patent and Trademark Office

Robert H. Underwood, PhD

Insights & Events / Media

Burlington, Massachusetts / McDermott Event / February 13, 2018

Cambridge, Massachusetts / McDermott Event / October 4, 2017

Webinar / Speaking Engagements / September 28, 2017

Burlington, Massachusetts / McDermott Event / January 17, 2017

1